DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,380
+50 (0.31%)
At close: Jan 16, 2026
41.82%
Market Cap286.92B
Revenue (ttm)149.47B
Net Income (ttm)39.73M
Shares Out17.52M
EPS (ttm)2.27
PE Ratio7,222.47
Forward PEn/a
Dividend150.00 (0.92%)
Ex-Dividend DateDec 29, 2025
Volume119,588
Average Volume160,341
Open16,340
Previous Close16,330
Day's Range16,050 - 16,660
52-Week Range9,960 - 24,900
Beta-0.30
RSI41.48
Earnings DateFeb 6, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.